entyce.aratana.comEntyce® (capromorelin oral solution) for inappetence in dogs

Pet Owners Farm Animal Professionals Log In Log In Home Products Show submenu forProducts ” Dermatology Show submenu forDermatology ” Atopica® for Cats (cyclosporine oral solution) USP MODIFIED Atopica® (cyclosporine capsules) USP MODIFIED for Dogs Baytril® Otic (enrofloxacin/silver sulfadiazine) Emulsion Claro® (florfenicol, terbinafine, mometasone furoate) Otic Solution Surolan® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate) Veraflox® (pradofloxacin) Disease Management Show submenu forDisease Management ” Baytril® (enrofloxacin) Antibacterial Injectable Solution Baytril® (enrofloxacin) Antibacterial Tablets Bexacat™ (bexagliflozin tablets) Elura® (capromorelin oral solution) Entyce® (capromorelin oral solution) Percorten®-V (desoxycorticosterone pivalate injectable suspension) Tanovea® (rabacfosadine for injection) Varenzin™-CA1 (molidustat oral suspension) Canine Parvovirus mAb Vaccine Show submenu forVaccine ” TruCan™ for Dogs TruFel™ for Cats Rabvac® Parasitology Show submenu forParasitology ” Advantage Multi® for Cats (imidacloprid + moxidectin) Advantage Multi® for Dogs (imidacloprid + moxidectin) Advantage® II for Cats Advantage® II for Dogs Credelio® CAT (lotilaner) Credelio® (lotilaner) for Dogs Droncit® (praziquantel) Interceptor® Plus (milbemycin oxime/praziquantel) K9 Advantix® II for Dogs Profender® (emodepside/praziquantel) Seresto® for Cats Seresto® for Dogs Trifexis® (spinosad + milbemycin oxime) Pain Management Show submenu forPain Management ” Pain Portfolio Deramaxx® (deracoxib) Galliprant® (grapiprant tablets) Nocita® (bupivacaine liposome injectable suspension) Onsior® (robenacoxib) quellin® (carprofen) Zorbium® (buprenorphine transdermal solution) Vetspon® Education Show submenu forEducation ” Upcoming Events Elanco CE Courses Sponsored CE Courses Educational Articles Practice Management Support Resources Contact Services FAQs Pet Owners Farm Animal Professionals Why Choose Entyce® Product Information Dosing How It Works How To Apply Entyce® (capromorelin oral solution) Entyce is the only FDA-approved veterinary therapeutic for appetite stimulation in dogs. Order Now Product Label Prescribe Entyce with confidence Entyce® delivers visible results, with ~7/10 dog owners reporting increased appetite in just 4 days of treatment compared to 4.5/10 control dogs.¹ Dogs with long-term health conditions can safely take Entyce® throughout their treatment journey, even with a wide range of comorbidities.* Entyce works like the body’s own natural hunger hormone, ghrelin. Entyce increases appetite, leading to increased food consumption. Entyce Product Information Indication For appetite stimulation in dogs Formulation An oral solution Mode of Action Mimics ghrelin, triggering dogs to eat Frequency Safe to use daily for as long as it’s needed* Entyce Dosing Information Administer Entyce orally at a dose of 3 mg/kg (1.4 mg/lb) body weight once daily. Available by prescription only, Entyce for dogs is supplied as a 30 mg/mL oral solution, includes a syringe for ease of administration, and is available in three bottle sizes: 10 mL, 15 mL, and 30 mL. Entyce works like the body’s own natural hunger hormone, ghrelin Entyce is safe to use daily, leading to changes pet owners can see Willingness to eat Anticipation of mealtime Hunger behavior Enthusiasm for food Consider Entyce as an essential part of your treatment plan In the field study, 171 inappetent dogs were assessed for safety over 4 days 1 Dogs had a wide range of medical conditions. 1 Entyce was generally well tolerated. The most commonly observed adverse events included diarrhea, vomiting, elevated blood urea nitrogen, polydipsia, and hypersalivation. Toxicity was assessed for 12 consecutive months of treatment in healthy dogs, supporting safety at the labeled dose. 2 Findings included increased salivation, reddening/swollen paws, increased liver weights, and hepatocellular cytoplasmic vacuolation. More than a meal Entyce supports dogs facing long-term health challenges by addressing inappetence, which is essential for improving nutrition. 3 Contact Us Order Now Buy Now Buy Now Buy Now Buy Now Buy Now Buy Now Entyce® (capromorelin oral solution) Resources 2021 Proceedings: Managing appetite disorders and weight loss in patients with chronic conditions Download PDF Safety Information References *The effectiveness of Entyce has not been studied beyond 4 days in the clinical study. INDICATION : For appetite stimulation in dogs. IMPORTANT SAFETY INFORMATION : For use in dogs only. Do not use in dogs that have a hypersensitivity to capromorelin. Use with caution in dogs with hepatic dysfunction or renal insufficiency. The safe use of Entyce has not been evaluated in breeding, pregnant or lactating dogs. The most common adverse reactions included diarrhea, vomiting, elevated blood urea nitrogen, polydipsia and hypersalivation. Please see Entyce product label for full prescribing information. 1 Zollers B et al. J Vet Intern Med 2016; 30(6): 1851–1857. 2 Zollers B et al. J Vet Pharmacol Therap 2017; 40: 248–255. 3 Zollers B et al. BMC Vet Res 2017; 13(10):...